The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 18, 2025
Filed:
Dec. 09, 2021
Applicants:
Wisconsin Alumni Research Foundation (Warf), Madison, WI (US);
The University of Tokyo, Tokyo, JP;
Inventors:
Assignees:
Wisconsin Alumni Research Foundation (WARF), Madison, WI (US);
The University of Tokyo, Tokyo, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/145 (2006.01); A61K 9/00 (2006.01); A61P 31/16 (2006.01); C07K 14/005 (2006.01); C12N 7/00 (2006.01); C12N 9/24 (2006.01); C12N 15/63 (2006.01);
U.S. Cl.
CPC ...
A61K 39/145 (2013.01); A61K 9/0019 (2013.01); A61K 9/0043 (2013.01); A61P 31/16 (2018.01); C07K 14/005 (2013.01); C12N 7/00 (2013.01); C12N 9/2402 (2013.01); C12N 15/63 (2013.01); C12N 2760/16021 (2013.01); C12N 2760/16022 (2013.01); C12N 2760/16034 (2013.01); C12N 2760/16051 (2013.01); C12Y 302/01018 (2013.01);
Abstract
Modified influenza virus neuraminidases are described herein that improve viral replication, thus improving the yield of vaccine viruses. Expression of such modified. neuraminidases by influenza virus may also stabilize co-expressed hemagglutinins so that the hemagglutinins do not undergo mutation.